Infinimmune

InfinimmuneInfinimmune
Infinimmune

Infinimmune

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Website
DR 202017Active22Alameda, United States
Rate
Advertise here

About

Infinimmune is a biotechnology company focused on discovering and developing next-generation antibody therapeutics directly from the human immune system. They leverage their proprietary Anthrobody® platform and GLIMPSE™ antibody language model to identify and optimize fully human antibodies for the treatment of atopic dermatitis, other inflammatory diseases, and cancer.
Frequently asked

What does Infinimmune do?

Infinimmune is a biotechnology company focused on discovering and developing next-generation antibody therapeutics directly from the human immune system. They leverage their proprietary Anthrobody® platform and GLIMPSE™ antibody language model to identify and optimize fully human antibodies for the treatment of atopic dermatitis, other inflammatory diseases, and cancer.

What is Infinimmune's Effective Domain Rating?

StartupHub's Effective Domain Rating for Infinimmune is 60 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 20, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.

Is Infinimmune trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Infinimmune is 82 out of 100, based on site security posture and privacy practices.

What is Infinimmune's revenue?

StartupHub estimates Infinimmune's annual revenue at $2.5M (range $1.4M to $7.2M, 69% confidence), based on comparable companies in the sector.

What is Infinimmune's valuation?

StartupHub estimates Infinimmune's effective valuation at $300.0M (range $187.5M to $450.0M, 24% confidence), based on comparable companies in the sector.

How much funding has Infinimmune raised?

Infinimmune has raised a total of $75M in funding. The most recent round on record is Series A.

Where is Infinimmune headquartered?

Infinimmune is headquartered in Alameda, United States.

When was Infinimmune founded?

Infinimmune was founded in 2017.

What industry does Infinimmune operate in?

Infinimmune operates in Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech, Biotech, Drug Discovery.

How many employees does Infinimmune have?

Infinimmune has approximately 22 people on record.

HEADCOUNT
22
DOMAIN RATING
20
New entrants in Biotechnology
Last 90 days
8
New entrants
2.7
Per month
0.6
Per week
Most recent
Galatek

Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.

Jul 13
Raven4batchrecords

Digital batch record software for pharmaceutical and biotech manufacturing.

Jul 9
Trofinetide

Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.

Jun 8
Peptideplus

AI-powered platform for peptide design and discovery.

May 30
Nanorobotics

A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.

May 28
Matrixcode

MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.

May 27
Cypherpunkcode

A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.

May 26
Pairx

Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.

May 21

An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.